Sagent Pharmaceuticals, which markets generic injectable drugs to the hospital market, will see its quiet period end on Monday, May 30. On April 19, the company raised $92 million by offering 5.75 million shares at $16, at high end of the range of $14 to $16. ...read more
Sagent Pharmaceuticals, which markets generic injectable drugs to hospitals, raised $92 million by offering 5.8 million shares (15% more than originally planned) at $16, at high end of the range of $14 to $16. Sagent Pharmaceuticals plans to list on the NASDAQ...read more
Sagent Pharmaceuticals, aninjectable pharmaceutical company with 21 marketed and 45 pipeline products, announced terms for its IPO on Wednesday. The Schaumburg, IL-based company plans to raise $75 million by offering 5 million shares at a price range of $14 to...read more
Sagent Pharmaceuticals, an injectable pharmaceutical company with 21 marketed and 45 pipeline products, filed on Monday with the SEC to raise up to $100 million in an initial public offering. The Schaumburg, IL-based company, which was founded in 2006 and...read more
Sagent Pharmaceuticals quiet period ends May 30
Sagent Pharmaceuticals, which markets generic injectable drugs to the hospital market, will see its quiet period end on Monday, May 30. On April 19, the company raised $92 million by offering 5.75 million shares at $16, at high end of the range of $14 to $16. ...read more
Sagent Pharmaceuticals prices upsized IPO at $16, high end of the range
Sagent Pharmaceuticals, which markets generic injectable drugs to hospitals, raised $92 million by offering 5.8 million shares (15% more than originally planned) at $16, at high end of the range of $14 to $16. Sagent Pharmaceuticals plans to list on the NASDAQ...read more
Sagent Pharmaceuticals reveals IPO terms
Sagent Pharmaceuticals, aninjectable pharmaceutical company with 21 marketed and 45 pipeline products, announced terms for its IPO on Wednesday. The Schaumburg, IL-based company plans to raise $75 million by offering 5 million shares at a price range of $14 to...read more
Sagent Pharmaceuticals files for $100 million IPO
Sagent Pharmaceuticals, an injectable pharmaceutical company with 21 marketed and 45 pipeline products, filed on Monday with the SEC to raise up to $100 million in an initial public offering. The Schaumburg, IL-based company, which was founded in 2006 and...read more